235 related articles for article (PubMed ID: 25929729)
1. Plasma cell leukemia: Clinicopathologic, immunophenotypic and cytogenetic characteristics of 4 cases.
Alghasham N; Alnounou R; Alzahrani H; Alsharif F
Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):71-7. PubMed ID: 25929729
[TBL] [Abstract][Full Text] [Related]
2. Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation.
Johnson MR; Del Carpio-Jayo D; Lin P; Giralt S; Anderlini P; Champlin RE; Khouri IF; Vadhan-Raj S; Medeiros LJ; Bueso-Ramos CE
Ann Diagn Pathol; 2006 Oct; 10(5):263-8. PubMed ID: 16979517
[TBL] [Abstract][Full Text] [Related]
3. A case of CD138-/CD19+/CD4+ IgD plasma cell leukemia.
Sorigue M; Juncà J; Gassiot S; Millá F; Mate JL; Navarro JT
Cytometry B Clin Cytom; 2015 Jan; 88(1):69-73. PubMed ID: 24715427
[TBL] [Abstract][Full Text] [Related]
4. Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics.
García-Sanz R; Orfão A; González M; Tabernero MD; Bladé J; Moro MJ; Fernández-Calvo J; Sanz MA; Pérez-Simón JA; Rasillo A; Miguel JF
Blood; 1999 Feb; 93(3):1032-7. PubMed ID: 9920853
[TBL] [Abstract][Full Text] [Related]
5. Significantly better prognosis for patients with primary plasma cell leukemia than for patients with secondary plasma cell leukemia.
Cha CH; Park CJ; Huh JR; Chi HS; Suh CW; Kang YK
Acta Haematol; 2007; 118(3):178-82. PubMed ID: 17934254
[TBL] [Abstract][Full Text] [Related]
6. Plasma cell leukemia: a rare condition.
Jiménez-Zepeda VH; Domínguez VJ
Ann Hematol; 2006 Apr; 85(4):263-7. PubMed ID: 16416115
[TBL] [Abstract][Full Text] [Related]
7. Primary plasma cell leukemia: A report of two cases of a rare and aggressive variant of plasma cell myeloma with the review of literature.
Gangadhar P; Ahmed Z; Pai MR; Sandhya I
Indian J Pathol Microbiol; 2016; 59(4):541-544. PubMed ID: 27721294
[TBL] [Abstract][Full Text] [Related]
8. Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment.
Pérez-Andrés M; Almeida J; Martín-Ayuso M; Moro MJ; Martín-Nuñez G; Galende J; Borrego D; Rodríguez MJ; Ortega F; Hernandez J; Moreno I; Domínguez M; Mateo G; San Miguel JF; Orfao A; ;
Leukemia; 2005 Mar; 19(3):449-55. PubMed ID: 15674420
[TBL] [Abstract][Full Text] [Related]
9. Plasma cell leukemia: a report on 15 patients.
Bernasconi C; Castelli G; Pagnucco G; Brusamolino E
Eur J Haematol Suppl; 1989; 51():76-83. PubMed ID: 2697596
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric immunophenotypic characteristics of 36 cases of plasma cell leukemia.
Kraj M; Kopeć-Szlęzak J; Pogłód R; Kruk B
Leuk Res; 2011 Feb; 35(2):169-76. PubMed ID: 20553988
[TBL] [Abstract][Full Text] [Related]
11. Plasma cell leukemia: from biology to treatment.
Jelinek T; Kryukov F; Rihova L; Hajek R
Eur J Haematol; 2015 Jul; 95(1):16-26. PubMed ID: 25778450
[TBL] [Abstract][Full Text] [Related]
12. Aggressive primary plasma cell leukemia with skin manifestations, trisomy 8 and molecular oligoclonal features.
Robak T; Urbańska-Rys H; Robak E; Bartkowiak J; Strzelecka B; Biernat W; Kordek R
Leuk Lymphoma; 2002 May; 43(5):1067-73. PubMed ID: 12148888
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic profile of plasma cell leukemia: a retrospective study in a reference cancer center in India and review of literature.
Tembhare PR; Subramanian PG; Sehgal K; Yajamanam B; Kumar A; Gadge V; Inamdar N; Gujral S
Indian J Pathol Microbiol; 2011; 54(2):294-8. PubMed ID: 21623077
[TBL] [Abstract][Full Text] [Related]
15. Response of primary plasma cell leukemia to the combination of bortezomib and dexamethasone: do specific cytogenetic and immunophenotypic characteristics influence treatment outcome?
Katodritou E; Verrou E; Gastari V; Hadjiaggelidou C; Terpos E; Zervas K
Leuk Res; 2008 Jul; 32(7):1153-6. PubMed ID: 18083228
[TBL] [Abstract][Full Text] [Related]
16. Thirty patients with primary plasma cell leukemia: a single center experience.
Colović M; Janković G; Suvajdzić N; Milić N; Dordević V; Janković S
Med Oncol; 2008; 25(2):154-60. PubMed ID: 18488157
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood polyclonal plasmacytosis mimicking plasma cell leukemia in patients with angioimmunoblastic T-cell lymphoma: report of 3 cases and review of the literature.
Ahsanuddin AN; Brynes RK; Li S
Int J Clin Exp Pathol; 2011 Apr; 4(4):416-20. PubMed ID: 21577327
[TBL] [Abstract][Full Text] [Related]
18. Plasma cell leukemia: Single institution experience.
Babu KG; Jacob LA; Agarwal A; Lakshmaiah KC; Lokanatha D; Suresh Babu MC; Rajeev LK; Lokesh KN; Rudresha AH
Indian J Cancer; 2016; 53(4):619-620. PubMed ID: 28485366
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotype and DNA content of myeloma cells in primary plasma cell leukemia.
Shimazaki C; Gotoh H; Ashihara E; Oku N; Inaba T; Murakami S; Itoh K; Ura Y; Nakagawa M; Fujita N
Am J Hematol; 1992 Mar; 39(3):159-62. PubMed ID: 1546712
[TBL] [Abstract][Full Text] [Related]
20. Plasma cell leukemia--a case report.
Badhe BA; Basu D; Toi PCh; Dutta TK; Ghotekar LH
Indian J Pathol Microbiol; 2003 Jul; 46(3):484-7. PubMed ID: 15025318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
